Stocktoria

Scilex Holding Co SCLX

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-01-11 · LEI

Scilex Holding Co statistics & valuation

Market cap$60.4M
P / S2.0×
P / FCF16.4×
Net margin-1236.4%
FCF margin12.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-201.70% -282.40% -61.40% -244.60% -128.70% -1236.40% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-149.70% -114.40% -133.10% -225.60% -147.40% -1143.70% 202020212022202320242025
Return on equity (%)
-64.50% 202020212022202320242025
Shares outstanding
3.5M 132.9M 141.3M 130.3M 5.2M 7.0M 202020212022202320242025
Net debt ($)
$67.7M -$2.2M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-23821.00% -113.50% -27.00% -112.90% -78.30% -102.50% 202020212022202320242025
Free cash flow margin (%)
-133.60% -91.50% 56.00% -44.40% 34.20% 12.20% 202020212022202320242025
Debt / equity (×)
0.00× 202020212022202320242025
EPS ($)
-$0.36 -$0.67 -$0.17 -$1.28 -$8.05 -$36.48 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-1143.7%-147.4%-225.6%-133.1%-114.4%-149.7%
Net margin-1236.4%-128.7%-244.6%-61.4%-282.4%-201.7%
FCF margin12.2%34.2%-44.4%56.0%-91.5%-133.6%
Return on assets-102.5%-78.3%-112.9%-27.0%-113.5%-23821.0%
Return on equity176.6%37.8%66.1%-64.5%39.5%33.5%
Debt / equity———0.00×-0.32×—
Current ratio0.080.160.190.660.140.17

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.